Delehedde, C.; Chocry, M.; Thétiot-Laurent, S.; Garrouste, F.; Culcasi, M.; Kovacic, H.; Pietri, S.
Metformin-Derived Hybrid Molecules for Glioblastoma Treatment. Proceedings 2019, 22, 83.
https://doi.org/10.3390/proceedings2019022083
AMA Style
Delehedde C, Chocry M, Thétiot-Laurent S, Garrouste F, Culcasi M, Kovacic H, Pietri S.
Metformin-Derived Hybrid Molecules for Glioblastoma Treatment. Proceedings. 2019; 22(1):83.
https://doi.org/10.3390/proceedings2019022083
Chicago/Turabian Style
Delehedde, Caroline, Mathieu Chocry, Sophie Thétiot-Laurent, Françoise Garrouste, Marcel Culcasi, Hervé Kovacic, and Sylvia Pietri.
2019. "Metformin-Derived Hybrid Molecules for Glioblastoma Treatment" Proceedings 22, no. 1: 83.
https://doi.org/10.3390/proceedings2019022083
APA Style
Delehedde, C., Chocry, M., Thétiot-Laurent, S., Garrouste, F., Culcasi, M., Kovacic, H., & Pietri, S.
(2019). Metformin-Derived Hybrid Molecules for Glioblastoma Treatment. Proceedings, 22(1), 83.
https://doi.org/10.3390/proceedings2019022083